Bengaluru-based healthtech startup Pulse has raised $4 million in a seed funding round led by a consortium of prominent investors. The capital will be used to scale its AI-powered preventive healthcare platform, expand its user base, enhance product features, and strengthen partnerships with hospitals, diagnostic chains, and insurance providers across India
Glimpse:
Pulse, a preventive health platform leveraging AI for personalized wellness insights, early risk detection, and chronic disease management, has closed a $4 million seed round. The funding round was led by early-stage investors with participation from health-focused angels and family offices. The company plans to use the funds to accelerate product development (including advanced symptom prediction, nutrition coaching, and telemedicine integration), grow its team, expand marketing efforts, and deepen collaborations with healthcare providers to reach millions of users in tier-1, tier-2, and tier-3 cities.
Pulse, a fast-growing Bengaluru-based healthtech startup focused on preventive and personalized healthcare, has successfully raised $4 million in a seed funding round announced on February 26, 2026. The round was led by a group of prominent early-stage investors specializing in healthtech and consumer wellness, with participation from several high-profile angel investors and family offices from India and the US. The funding comes at a time when preventive health platforms are gaining significant traction in India amid rising awareness of chronic diseases, lifestyle-related risks, and the need for proactive wellness management.
Founded in 2023 by a team of IIT and IIM alumni with prior experience in digital health and AI, Pulse offers an AI-driven mobile app that provides users with personalized health scores, early risk alerts for conditions like diabetes, hypertension, cardiovascular issues, and metabolic syndrome, customized nutrition and exercise plans, medication reminders, and virtual consultations with physicians and nutritionists. The platform aggregates data from wearables, self-reported symptoms, lab reports, and lifestyle inputs to deliver actionable insights and preventive recommendations tailored to Indian users’ genetic, dietary, and environmental contexts.
The fresh capital will be deployed across several key priorities. Pulse plans to accelerate product development by adding advanced features such as predictive symptom analysis, integration with more wearable devices and diagnostic labs, multilingual support for regional languages, and enhanced telemedicine capabilities. A significant portion of the funds will go toward team expansion, particularly in AI/ML engineering, clinical validation, and user growth teams. The company also intends to intensify marketing and user acquisition efforts in tier-2 and tier-3 cities, where preventive health awareness is growing but structured solutions remain limited.
Speaking on the funding round, Pulse’s founders highlighted that India is witnessing a shift from reactive to preventive healthcare, driven by rising chronic disease prevalence, increasing smartphone penetration, and greater health consciousness post-pandemic. They emphasized that the investment will help scale the platform to millions of users and build a truly India-first preventive health ecosystem.
The round reflects continued investor enthusiasm for healthtech startups that combine AI, personalization, and accessibility to address large-scale public health challenges. Pulse plans to use the capital to achieve significant user growth and operational milestones ahead of a potential Series A round in 2027.
“India is moving from treating illness to preventing it. With this funding, Pulse is positioned to become the go-to platform for millions who want to take control of their health proactively and affordably.”
By
HB Team
